Polares Medical
Develops the MRace Posterior Leaflet Replacement system, a transcatheter therapy for mitral regurgitation
$50MSeries C
Role not disclosedActivity from announced rounds
Develops the MRace Posterior Leaflet Replacement system, a transcatheter therapy for mitral regurgitation
Cellares manufactures cell therapies for drug developers using automated production and quality-control systems deployed through its Smart Factory network.